Plant ID: NPO20150
Plant Latin Name: Erythrina Sacleuxii
Taxonomy Genus: Erythrina
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
1899109
Plant-of-the-World-Online:
n.a.
Ingredient ID: NPC95594
Ingredient ID: NPC92117
Ingredient ID: NPC90829
Ingredient ID: NPC85694
Ingredient ID: NPC83670
Ingredient ID: NPC74595
Ingredient ID: NPC67917
Ingredient ID: NPC51700
Ingredient ID: NPC49627
Ingredient ID: NPC49599
Ingredient ID: NPC482074
Ingredient ID: NPC468984
Ingredient ID: NPC42853
Ingredient ID: NPC40702
Ingredient ID: NPC314743
Ingredient ID: NPC30583
Ingredient ID: NPC304741
Ingredient ID: NPC29883
Ingredient ID: NPC289196
Ingredient ID: NPC281131
Ingredient ID: NPC270689
Ingredient ID: NPC264317
Ingredient ID: NPC263548
Ingredient ID: NPC259166
Ingredient ID: NPC253662
Ingredient ID: NPC239966
Ingredient ID: NPC225723
Ingredient ID: NPC225710
Ingredient ID: NPC225616
Ingredient ID: NPC213659
Ingredient ID: NPC20791
Ingredient ID: NPC200574
Ingredient ID: NPC178383
Ingredient ID: NPC178134
Ingredient ID: NPC172250
Ingredient ID: NPC169749
Ingredient ID: NPC149875
Ingredient ID: NPC144118
Ingredient ID: NPC139546
Ingredient ID: NPC127684
Ingredient ID: NPC121171
Ingredient ID: NPC116775
Ingredient ID: NPC107775
Ingredient ID: NPC101658
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Cysteine protease | CASP6 | Caspase-6 | P55212 | CHEMBL3308 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Therapeutic Target | Enzyme | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | P27695 | CHEMBL5619 |
Therapeutic Target | Enzyme | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Therapeutic Target | Enzyme | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Therapeutic Target | Enzyme | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Therapeutic Target | Enzyme | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Therapeutic Target | Enzyme | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Therapeutic Target | Enzyme | CES1 | Acyl coenzyme A:cholesterol acyltransferase | P23141 | CHEMBL2265 |
Therapeutic Target | Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Therapeutic Target | Isomerase | TOP2A | DNA topoisomerase II alpha | P11388 | CHEMBL1806 |
Therapeutic Target | Lyase | GLO1 | Glyoxalase I | Q04760 | CHEMBL2424 |
Therapeutic Target | Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Therapeutic Target | Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Therapeutic Target | Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
Therapeutic Target | Methyl-lysine/arginine binding protein | L3MBTL1 | Lethal(3)malignant brain tumor-like protein 1 | Q9Y468 | CHEMBL1287622 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | RORC | Nuclear receptor ROR-gamma | P51449 | CHEMBL1741186 |
Therapeutic Target | Other cytosolic protein | HSPA1A | Heat shock 70 kDa protein 1 | P0DMV8 | CHEMBL5460 |
Therapeutic Target | Oxidoreductase | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Therapeutic Target | Oxidoreductase | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Therapeutic Target | Oxidoreductase | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Therapeutic Target | Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Therapeutic Target | Phosphodiesterase | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Therapeutic Target | Protein Kinase | EGFR | Epidermal growth factor receptor erbB1 | P00533 | CHEMBL203 |
Therapeutic Target | Protein Kinase | YES1 | Tyrosine-protein kinase YES | P07947 | CHEMBL2073 |
Therapeutic Target | Protein Kinase | SRC | Tyrosine-protein kinase SRC | P12931 | CHEMBL267 |
Therapeutic Target | Protein Kinase | CDK1 | Cyclin-dependent kinase 1 | P06493 | CHEMBL308 |
Therapeutic Target | Protein Kinase | INSR | Insulin receptor | P06213 | CHEMBL1981 |
Therapeutic Target | Protein Kinase | KDR | Vascular endothelial growth factor receptor 2 | P35968 | CHEMBL279 |
Therapeutic Target | Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Therapeutic Target | Protein Kinase | TEK | Tyrosine-protein kinase TIE-2 | Q02763 | CHEMBL4128 |
Therapeutic Target | Protein Kinase | AURKB | Serine/threonine-protein kinase Aurora-B | Q96GD4 | CHEMBL2185 |
Therapeutic Target | Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Therapeutic Target | Protein Kinase | AXL | Tyrosine-protein kinase receptor UFO | P30530 | CHEMBL4895 |
Therapeutic Target | Protein Kinase | CSNK2A1 | Casein kinase II alpha | P68400 | CHEMBL3629 |
Therapeutic Target | Protein Kinase | MET | Hepatocyte growth factor receptor | P08581 | CHEMBL3717 |
Therapeutic Target | Protein Kinase | IGF1R | Insulin-like growth factor I receptor | P08069 | CHEMBL1957 |
Therapeutic Target | Protein Kinase | NUAK1 | NUAK family SNF1-like kinase 1 | O60285 | CHEMBL5784 |
Drug Transporter | SLC superfamily of solute carriers | SLC22A6 | Solute carrier family 22 member 6 | Q4U2R8 | CHEMBL1641347 |
Therapeutic Target | Small molecule receptor (family A GPCR) | ADRA2A | Alpha-2a adrenergic receptor | P08913 | CHEMBL1867 |
Therapeutic Target | Small molecule receptor (family A GPCR) | DRD1 | Dopamine D1 receptor | P21728 | CHEMBL2056 |
Therapeutic Target | Small molecule receptor (family A GPCR) | GPR35 | G-protein coupled receptor 35 | Q9HC97 | CHEMBL1293267 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Transcription factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
Therapeutic Target | Transcription factor | SMAD3 | Mothers against decapentaplegic homolog 3 | P84022 | CHEMBL1293258 |
Therapeutic Target | Transcription factor | RELA | Nuclear factor NF-kappa-B p65 subunit | Q04206 | CHEMBL5533 |
Therapeutic Target | Transferase | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Q11130 | CHEMBL3596077 |
Therapeutic Target | Transferase | POLH | DNA polymerase eta | Q9Y253 | CHEMBL5542 |
Therapeutic Target | Transferase | POLI | DNA polymerase iota | Q9UNA4 | CHEMBL5391 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 234 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT05276895 | Effect of Natural Senolytic Agents & NLRP3 Inhibitors on Osteoarthritis | osteoarthritis | Quercetin (NPC20791) | NP level |
NCT02663596 | Safety and TDM of Continuous Infusion Vancomycin Through Continuous Renal Replacement Therapy Solution | kidney failure | Vancomycin (NPC314743) | NP level |
NCT00334412 | COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT00497601 | A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT00871104 | Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis | infective endocarditis | Vancomycin (NPC314743) | NP level |
NCT00003315 | Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection | infection | Amphotericin B (NPC67917) | NP level |
NCT01222702 | Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT01945281 | Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) | Candidiasis, Invasive | Amphotericin B (NPC67917) | NP level |
NCT01708278 | Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD) | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT01348204 | Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators | cystic fibrosis | Quercetin (NPC20791) | NP level |
NCT01293643 | A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) | bacterial vaginosis;vulvovaginal candidiasis | Amphotericin B (NPC67917) | NP level |
NCT00002316 | The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis | cryptococcal meningitis | Amphotericin B (NPC67917) | NP level |
NCT01032187 | Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT01839344 | Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes. | type 2 diabetes mellitus | Quercetin (NPC20791) | NP level |
NCT00077675 | Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) | infection | Vancomycin (NPC314743) | NP level |
NCT00001107 | Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants | candidiasis | Amphotericin B (NPC67917) | NP level |
NCT00124020 | Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus | bacterial pneumonia | Vancomycin (NPC314743) | NP level |
NCT01085760 | A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis | sclerosing cholangitis | Vancomycin (NPC314743) | NP level |
NCT05422885 | Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease | aging | Quercetin (NPC20791) | NP level |
NCT03595553 | Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection | infection | Vancomycin (NPC314743) | NP level |
NCT02504554 | Beneficial Bacteria Treatment for Autism | autism spectrum disorder | Vancomycin (NPC314743) | NP level |
NCT01184872 | Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections | infection | Vancomycin (NPC314743) | NP level |
NCT02865616 | MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00423657 | Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT02774382 | Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT01845727 | Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia | cutaneous Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT01375101 | Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus | oral lichen planus | Quercetin (NPC20791) | NP level |
NCT00163111 | A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. | candidiasis | Amphotericin B (NPC67917) | NP level |
NCT01922011 | Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006) | osteomyelitis | Vancomycin (NPC314743) | NP level |
NCT00228410 | Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections | skin disease | Vancomycin (NPC314743) | NP level |
NCT02424734 | Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis | Sepsis | Ampicillin (NPC468984) | NP level |
NCT04403568 | Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate | prostate cancer | Ursolic Acid (NPC51700) | NP level |
NCT05266807 | Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence | infection | Vancomycin (NPC314743) | NP level |
NCT03452189 | The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome | chronic kidney disease | Vancomycin (NPC314743) | NP level |
NCT00158730 | Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT00543608 | Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia | ventilator-associated pneumonia | Vancomycin (NPC314743) | NP level |
NCT02301221 | Effect of Fecal Microbiota Transplantation in Slow Transit Constipation | Constipation | Vancomycin (NPC314743) | NP level |
NCT03796650 | Fecal Transplantation for Primary Clostridium Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT04968951 | Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC) | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT04851821 | The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) | COVID-19 | Quercetin (NPC20791) | NP level |
NCT00451711 | Intermittent Liposomal Amphotericin B Primary Prophylaxis | acute myeloid leukemia | Amphotericin B (NPC67917) | NP level |
NCT01199783 | Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment | diabetic foot | Vancomycin (NPC314743) | NP level |
NCT01058174 | Liver Transplant European Study Into the Prevention of Fungal Infection | fungal infectious disease | Amphotericin B (NPC67917) | NP level |
NCT01400867 | Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections | infection | Vancomycin (NPC314743) | NP level |
NCT00050401 | Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support | pneumonia | Vancomycin (NPC314743) | NP level |
NCT02099240 | Patients Response to Early Switch To Oral:Osteomyelitis Study | osteomyelitis | Vancomycin (NPC314743) | NP level |
NCT01792804 | Staphylococcus Aureus Bacteremia Antibiotic Treatment Options | Staphylococcus aureus infection | Vancomycin (NPC314743) | NP level |
NCT04247542 | ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT01252732 | Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection | abscess;cellulitis;infection;inflammation | Vancomycin (NPC314743) | NP level |
NCT00986713 | Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT03506347 | Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement | Arthropathy | Vancomycin (NPC314743) | NP level |
NCT00314951 | Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018) | commensal Clostridium infectious disease;Diarrhea | Vancomycin (NPC314743) | NP level |
NCT03673956 | Topical Antibiotics in Chronic Rhinosinusitis | sinusitis | Vancomycin (NPC314743) | NP level |
NCT00770341 | A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002) | Staphylococcus aureus infection | Vancomycin (NPC314743) | NP level |
NCT02426918 | Study of Debio 1450 for Bacterial Skin Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT00001017 | Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS | cryptococcal meningitis | Amphotericin B (NPC67917) | NP level |
NCT02743234 | Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT02730962 | Interventional Bioremediation of Microbiota in Metabolic Syndrome | prediabetes syndrome | Vancomycin (NPC314743) | NP level |
NCT01570192 | Clinical Trials to Reduce the Risk of Antimicrobial Resistance | bacterial pneumonia | Vancomycin (NPC314743) | NP level |
NCT00467883 | Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment | mucormycosis | Amphotericin B (NPC67917) | NP level |
NCT02765256 | Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease | Crohn's disease | Vancomycin (NPC314743) | NP level |
NCT00047827 | Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT01798537 | Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections | bacteriemia;pneumonia | Vancomycin (NPC314743) | NP level |
NCT03685747 | Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis | peritonitis | Vancomycin (NPC314743) | NP level |
NCT04907253 | Quercetin in Coronary Artery By-pass Surgery | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT00695903 | Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia | infective endocarditis | Vancomycin (NPC314743) | NP level |
NCT00523965 | Combination Therapy in Indian Visceral Leishmaniasis | Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT02007603 | Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients | infection | Ampicillin (NPC468984) | NP level |
NCT02374853 | Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial) | infection | Vancomycin (NPC314743) | NP level |
NCT00062647 | Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia | gram-positive bacterial infections | Vancomycin (NPC314743) | NP level |
NCT00936910 | Antifungal Locks to Treat Fungal-related Central Line Infections | fungal infectious disease | Amphotericin B (NPC67917) | NP level |
NCT00630513 | T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam | infection | Ampicillin (NPC468984) | NP level |
NCT01764750 | Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics | infection | Vancomycin (NPC314743) | NP level |
NCT03989271 | Biological Effects of Quercetin in COPD | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT03546829 | Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer | non-small cell lung carcinoma | Vancomycin (NPC314743) | NP level |
NCT05370885 | VE202 in Patients With Mild-to-Moderate Ulcerative Colitis | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT02607618 | Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 | infection | Vancomycin (NPC314743) | NP level |
NCT00003805 | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count | infection | Vancomycin (NPC314743) | NP level |
NCT03759041 | A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT04799236 | Treatment of Mucosal Bolivian Leishmaniasis | mucocutaneous Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT02801656 | Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT01226992 | Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT01515020 | Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia | nosocomial infection | Vancomycin (NPC314743) | NP level |
NCT02344511 | Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis | osteomyelitis | Vancomycin (NPC314743) | NP level |
NCT01925066 | Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation | staphylococcal pneumonia;Staphylococcus aureus infection | Vancomycin (NPC314743) | NP level |
NCT00177684 | Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) | fungal infectious disease | Amphotericin B (NPC67917) | NP level |
NCT00418951 | Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections | acute myeloid leukemia;myelodysplastic syndrome | Amphotericin B (NPC67917) | NP level |
NCT02226484 | Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? | gastroesophageal reflux disease | Quercetin (NPC20791) | NP level |
NCT02790996 | Neonatal Vancomycin Trial | Neonatal sepsis | Vancomycin (NPC314743) | NP level |
NCT05076955 | Evaluating the Healing of Diabetic Foot Ulcers With Compounded Anti-Infective Irrigation Therapy | diabetic foot | Vancomycin (NPC314743) | NP level |
NCT01283581 | A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT02857582 | Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT01912820 | Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | prostate adenocarcinoma | Quercetin (NPC20791) | NP level |
NCT00001646 | Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT00624143 | Antifungal Prophylaxis in Pediatric Acute Leukemia | leukemia | Amphotericin B (NPC67917) | NP level |
NCT02202135 | Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. | infection | Vancomycin (NPC314743) | NP level |
NCT00371995 | Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT03196921 | Efficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection | infection | Amphotericin B (NPC67917) | NP level |
NCT01594827 | Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) | cystic fibrosis | Vancomycin (NPC314743) | NP level |
NCT01857479 | A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis | allergic bronchopulmonary aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT00235651 | Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients | lung disease | Amphotericin B (NPC67917) | NP level |
NCT00428844 | Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci | osteomyelitis | Vancomycin (NPC314743) | NP level |
NCT00430937 | Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections | infection;skin disease | Vancomycin (NPC314743) | NP level |
NCT01499277 | Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections | infection | Vancomycin (NPC314743) | NP level |
NCT00263315 | Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT02656797 | Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis | Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT00145249 | Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis | cryptococcal meningitis | Amphotericin B (NPC67917) | NP level |
NCT01984684 | Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections | infection;bacterial disease | Vancomycin (NPC314743) | NP level |
NCT01438320 | Q-Trial in Patients With Hepatitis C | chronic hepatitis C virus infection | Quercetin (NPC20791) | NP level |
NCT04041791 | A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia | pneumonia | Ampicillin (NPC468984) | NP level |
NCT00847678 | Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS | cryptococcal meningitis | Amphotericin B (NPC67917) | NP level |
NCT03462459 | Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection | clostridium difficile infection;Diarrhea | Vancomycin (NPC314743) | NP level |
NCT02337933 | Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome | metabolic syndrome | Ursolic Acid (NPC51700) | NP level |
NCT00037050 | Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria | bacteriemia;gram-positive bacterial infections | Vancomycin (NPC314743) | NP level |
NCT03943459 | Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT00876824 | To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar | Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT04017468 | Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion | infection | Vancomycin (NPC314743) | NP level |
NCT02686853 | Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis | cryptococcal meningitis | Amphotericin B (NPC67917) | NP level |
NCT00269399 | A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) | commensal Clostridium infectious disease;Diarrhea | Vancomycin (NPC314743) | NP level |
NCT01067443 | Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT00008359 | Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment | cancer | Amphotericin B (NPC67917) | NP level |
NCT04946383 | Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging | aging | Quercetin (NPC20791) | NP level |
NCT02011958 | Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT00455416 | Dietary Intervention in Follicular Lymphoma | follicular lymphoma | Ellagic Acid (NPC178134);Quercetin (NPC20791) | NP level |
NCT03327727 | VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT03636659 | Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT00696969 | Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT02641236 | Gut Decontamination In Pediatric Allogeneic Hematopoietic | acute graft vs. host disease | Vancomycin (NPC314743) | NP level |
NCT03964493 | TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection | gram-positive bacterial infections | Vancomycin (NPC314743) | NP level |
NCT00832208 | Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT01339091 | Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections | abscess;cellulitis;infection | Vancomycin (NPC314743) | NP level |
NCT04502381 | Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis | mucormycosis | Amphotericin B (NPC67917) | NP level |
NCT02148601 | Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT00150852 | Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus. | infection | Vancomycin (NPC314743) | NP level |
NCT01551394 | Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset Sepsis | Sepsis | Ampicillin (NPC468984) | NP level |
NCT02629419 | CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis | Chronic mucocutaneous candidosis | Amphotericin B (NPC67917) | NP level |
NCT03827447 | Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT02179658 | A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD) | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT00701987 | Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma | melanoma | Betulinic Acid (NPC264317) | NP level |
NCT02025491 | Liposomal Amphotericin in Disseminated Leishmaniasis | Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT01437020 | SCH708980 With and Without AmBisome for Visceral Leishmaniasis | Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT00003031 | Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT01138852 | Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section | infection | Ampicillin (NPC468984) | NP level |
NCT01566552 | Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT00002742 | Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer | chronic myeloproliferative disorder;leukemia;multiple myeloma;myelodysplastic syndrome;infection | Amphotericin B (NPC67917) | NP level |
NCT01232595 | Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT04948814 | Application of Fecal Microbiota Transplantation in Children With ASD | autism spectrum disorder | Vancomycin (NPC314743) | NP level |
NCT01983683 | Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00216346 | Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT01433757 | Ampicillin for DYT-1 Dystonia Motor Symptoms | dystonic disorder | Ampicillin (NPC468984) | NP level |
NCT00107978 | Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus | staphylococcal skin infections | Vancomycin (NPC314743) | NP level |
NCT00003938 | Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients | cancer | Amphotericin B (NPC67917) | NP level |
NCT02686645 | Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT01191840 | Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection | bacteriemia | Vancomycin (NPC314743) | NP level |
NCT04011618 | Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | metabolic syndrome | Ellagic Acid (NPC178134) | NP level |
NCT02276482 | Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012) | skin disease | Vancomycin (NPC314743) | NP level |
NCT03216876 | A Study Of Ursolic Acid For Primary Sclerosing Cholangitis | sclerosing cholangitis | Ursolic Acid (NPC51700) | NP level |
NCT05320068 | Oral Vancomycin vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection | infection | Vancomycin (NPC314743) | NP level |
NCT02600611 | Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 | infection | Vancomycin (NPC314743) | NP level |
NCT01122771 | Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT00760006 | Preventing Complications in Cleft Palate Repair With Antibiotics | Cleft palate | Ampicillin (NPC468984) | NP level |
NCT00384527 | Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT00442832 | TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection | staphylococcal skin infections | Vancomycin (NPC314743) | NP level |
NCT05256693 | Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT04031833 | Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) | cryptococcal meningitis | Amphotericin B (NPC67917) | NP level |
NCT04816968 | Antibiotics Continuous Infusion at Home | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT02092935 | A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00879190 | Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis | chorioamnionitis | Ampicillin (NPC468984) | NP level |
NCT02848131 | Senescence in Chronic Kidney Disease | chronic kidney disease | Quercetin (NPC20791) | NP level |
NCT02432807 | Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis | bacterial conjunctivitis | Vancomycin (NPC314743) | NP level |
NCT03817125 | Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention | metastatic melanoma | Vancomycin (NPC314743) | NP level |
NCT01802073 | Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects | sclerosing cholangitis | Vancomycin (NPC314743) | NP level |
NCT00772447 | China Registration Study in Patients With Skin Infections | skin disease | Vancomycin (NPC314743) | NP level |
NCT04042077 | Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections | infection | Vancomycin (NPC314743) | NP level |
NCT01756924 | Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection | infection | Vancomycin (NPC314743) | NP level |
NCT04025567 | Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral | hepatocellular carcinoma | Vancomycin (NPC314743) | NP level |
NCT00108433 | Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections | bacteriemia;gram-positive bacterial infections | Vancomycin (NPC314743) | NP level |
NCT04267497 | Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT01310738 | Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT02227446 | Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO) | infection | Vancomycin (NPC314743) | NP level |
NCT01811732 | Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT03137173 | Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections | infection | Vancomycin (NPC314743) | NP level |
NCT03030248 | Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT01597505 | Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT03710122 | Vancomycin for Primary Sclerosing Cholangitis | sclerosing cholangitis | Vancomycin (NPC314743) | NP level |
NCT00945152 | Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT00952796 | A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections | infection | Ampicillin (NPC468984) | NP level |
NCT00370825 | Combination Chemotherapy for the Treatment of Indian Kala-Azar | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT04853199 | Quercetin In The Treatment Of SARS-COV 2 | COVID-19 | Quercetin (NPC20791) | NP level |
NCT00012467 | Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis | cryptococcal meningitis | Amphotericin B (NPC67917) | NP level |
NCT00076869 | MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037) | aspergillosis | Amphotericin B (NPC67917) | NP level |
NCT00002277 | A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections | fungal infectious disease | Amphotericin B (NPC67917) | NP level |
NCT01975662 | Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia | Staphylococcus aureus infection | Vancomycin (NPC314743) | NP level |
NCT00107952 | Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus | bacterial pneumonia | Vancomycin (NPC314743) | NP level |
NCT01987895 | Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00426933 | Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections | infection | Vancomycin (NPC314743) | NP level |
NCT03945448 | Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia | cryptococcal meningitis | Amphotericin B (NPC67917) | NP level |
NCT00815516 | Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis | candidiasis | Amphotericin B (NPC67917) | NP level |
NCT01994993 | Antibiotic Safety (SCAMP) | infection | Ampicillin (NPC468984) | NP level |
NCT00419770 | The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study | mucormycosis | Amphotericin B (NPC67917) | NP level |
NCT00091819 | Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus | staphylococcal skin infections | Vancomycin (NPC314743) | NP level |
NCT05062486 | A Study to Evaluate the Safety and Efficacy of RQC for AMD | age-related macular degeneration | Quercetin (NPC20791) | NP level |
NCT04775953 | DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia | bacteriemia | Vancomycin (NPC314743) | NP level |
NCT00000776 | Dexamethasone in Cryptococcal Meningitis | intracranial hypertension;cryptococcal meningitis | Amphotericin B (NPC67917) | NP level |
NCT02618187 | A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT05456022 | Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | mouth neoplasm | Quercetin (NPC20791) | NP level |
NCT05468372 | Amphotericin Versus Posaconazole for Pulmonary Mucormycosis | mucormycosis | Amphotericin B (NPC67917) | NP level |
NCT04983901 | PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN | hematopoietic and lymphoid cell neoplasm | Vancomycin (NPC314743) | NP level |
NCT00210899 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | staphylococcal skin infections;skin disease | Vancomycin (NPC314743) | NP level |
NCT00002159 | A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis | blastomycosis;histoplasmosis | Amphotericin B (NPC67917) | NP level |
NCT00106288 | Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia | candidiasis | Amphotericin B (NPC67917) | NP level |
NCT01720147 | Quercetin in Children With Fanconi Anemia; a Pilot Study | Fanconi anemia | Quercetin (NPC20791) | NP level |
NCT00346502 | Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia) | dysplastic nevus | Betulinic Acid (NPC264317) | NP level |
NCT03617445 | Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT01598311 | A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00177710 | Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study | fungal infectious disease | Amphotericin B (NPC67917) | NP level |
NCT04733534 | An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer | childhood cancer | Quercetin (NPC20791) | NP level |
NCT04018417 | Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections. | Fuchs endothelial corneal dystrophy | Amphotericin B (NPC67917) | NP level |
NCT02208063 | A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial | bacteriemia | Vancomycin (NPC314743) | NP level |
NCT04075526 | Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty | osteoarthritis | Vancomycin (NPC314743) | NP level |
NCT04138706 | Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT02037295 | Investigation of the Gut Microbiota in Regulating Nutrient Absorption in Humans | obesity | Vancomycin (NPC314743) | NP level |
NCT00424190 | Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT03105479 | Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT03187691 | Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia | acute lymphoblastic leukemia;acute myeloid leukemia | Amphotericin B (NPC67917) | NP level |
NCT03595566 | Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection | infection | Vancomycin (NPC314743) | NP level |
NCT04678154 | Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT | infection | Vancomycin (NPC314743) | NP level |
NCT01757236 | Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection | infection | Vancomycin (NPC314743) | NP level |
NCT00628719 | Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis | visceral Leishmaniasis | Amphotericin B (NPC67917) | NP level |
NCT04802837 | Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects | infection | Vancomycin (NPC314743) | NP level |
NCT02466698 | Intestinal Lavage for the Treatment of Severe C. Difficile Infections | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT04898348 | A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT02099240 | Patients Response to Early Switch To Oral:Osteomyelitis Study | osteomyelitis | Ampicillin (NPC468984) | NP level |
NCT03476317 | Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease | Crohn's disease | Vancomycin (NPC314743) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Meningitis due to Cryptococcus neoformansDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D01.10 |
NCT04031833,NCT00001017,NCT00002316,NCT00000776,NCT00012467,NCT00145249,NCT02686853,NCT00847678,NCT03945448
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
RORC,ACHE,XDH,FUT7,ELAVL3,ADRA2A,MET,NOX4,SNCA
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
CDK1,NOX4,AURKB,NPSR1,DRD1,TOP2A,ALOX15,CYP19A1,MET
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
ALOX12,XDH,TOP2A,CA12,CDK1,AURKB,CA7,NPSR1,CYP2C9
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
MET,CA12,CSNK2A3,LMNA,CYP1B1,KDR,DPP4,CYP19A1,POLH
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
AXL,KDR,FLT3,IGF1R,AHR,INSR,SRC
NCT00002742 |
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
DPP4,TOP2A,TP53,CDK1,AURKB,FLT3,SRC
NCT04983901 |
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
CDK1,AURKB,ALOX15,ACHE,NPSR1,TOP2A,HSPA1A,NOX4
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
KDM4E,ACHE,GPR35,HPGD,ELAVL3,ALOX15,CYP2C9,CYP1A1
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
CA12,DPP4,XDH,CYP1B1,CA7,ALOX5,MET,NOX4
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
EGFR,MET,TOP2A,TP53,FLT3,KDR,IGF1R
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
AHR,AXL,TP53,KDR,EGFR
NCT00418951,NCT00002742 |
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
AHR,ALOX5,DPP4,FLT3,RORC,RELA,TOP2A
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
KDR,EGFR,MET,HSPA1B,HSPA1A,TP53,TOP2A
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
SNCA,MET,INSR,FLT3,ACHE,TOP2A,KDR
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
DPP4,LMNA,SRC,ACHE,INSR,ADRA2A,SNCA
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
EGFR,MET,CSNK2A1,IGF1R,KDR,TOP2A
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
MET,KDR,TOP2A,TP53,SRC,FLT3
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
ALOX5,AKR1B1,ADRA2A,IGF1R,ACHE,INSR
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
SRC,KDR,TP53,MET,TOP2A,EGFR
|
BacteraemiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MA15.0 |
NCT00108433,NCT04775953,NCT01798537,NCT01191840,NCT02208063,NCT00037050
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
CDK1,CYP1A2,AKR1B1,AURKB,TOP2A,CYP2C9
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA,EGFR,AXL,XDH,GPR35,CYP19A1
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
CA12,CDK1,AURKB,FUT7,TOP2A,ELAVL3
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CA12,CYP1A2,AURKB,TOP2A,MET,CYP1A1
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
HSPA1A,HSPA1B,EGFR
NCT05076955,NCT01199783 |
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
EGFR,MET,KDR,TYR
NCT00701987 |
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
AURKB,KDR,INSR,AKR1B1,DPP4
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
TP53,EGFR,IGF1R,SRC,TOP2A
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
TEK,TP53,MET,DPP4,CES1
|
Skin diseaseDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA00-EM0Z |
NCT00430937,NCT00772447,NCT02276482,NCT00210899,NCT00228410
|
Skin fungal infection disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA60 |
NCT00177684,NCT00177710,NCT00002277,NCT01058174,NCT00936910
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
NCT04968951,NCT05370885,NCT02618187,NCT03759041,NCT04898348
|
CandidosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F23 |
NCT00001107,NCT00106288,NCT00815516,NCT01945281,NCT00163111
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
DPP4,AXL,ACHE,CYP19A1,MET
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NOX4,TYR,NPSR1,MET,CYP1A1
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
CA12,CDK1,AURKB,XDH,TOP2A
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
DPP4,SMAD3,FUT7,CYP1B1,NOX4
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
HSPA1A,AKR1B1,CYP19A1,HSPA1B
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
FLT3,KDR,SRC,TP53
|
Malignant digestive organ neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C11 |
HSPA1A,KDR,SRC,HSPA1B
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
ACHE,SNCA,SRC,DRD1
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
EGFR,TP53,MET,KDR
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
RORC,INSR
NCT02765256,NCT03476317 |
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
AXL,TP53,SRC,EGFR
|
Motor neuron diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60 |
HSPA1A,IGF1R,SRC,HSPA1B
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
XDH,IGF1R
NCT03452189,NCT02848131 |
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
SRC,FLT3,HSPA1A,HSPA1B
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
ALOX5,RELA,ABCG2,AKR1B1
|
NADisease Category: NADisease ICD-11 Code: NA |
NOX4,MET
NCT01252732,NCT00235651 |
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
EGFR,KDR,MET
NCT03546829 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
INSR,RELA,DPP4
NCT01839344 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
TOP2A,RELA,SRC,RORC
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
CDK1,FLT3,TEK,TOP2A
|
Other specified pyogenic bacterial infection of skin and subcutaneous tissueDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B7Y |
NCT01975662,NCT01925066,NCT01792804,NCT00770341
|
Osteomyelitis or osteitisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB84 |
NCT00428844,NCT02099240,NCT01922011,NCT02344511
|
Staphylococcal/streptococcal diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B5Y |
NCT00091819,NCT00442832,NCT00107978,NCT00210899
|
MucormycosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F2C |
NCT00419770,NCT00467883,NCT04502381,NCT05468372
|
Primary sclerosing cholangitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.2 |
NCT01802073,NCT03710122,NCT03216876,NCT01085760
|
Gram-positive bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B74-1F40 |
NCT03964493,NCT00062647,NCT00037050,NCT00108433
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
CA12,CDK1,TOP2A,HSD17B2
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
ADRA2A,TOP2A,HPGD,CYP1A1
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NOX4,IGF1R,FUT7,ABCG2
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
AXL,MET,GPR35,FLT3
|
Ebola virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D60.01 |
AXL,HSD17B2,ACHE,MET
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
HSPA1A,HSPA1B,SMAD3
NCT04042077,NCT01757236,NCT00002742,NCT04017468,NCT00630513,NCT03137173,NCT01252732,NCT04678154,NCT01764750,NCT01138852,NCT00952796,NCT01994993,NCT01339091,NCT03595566,NCT01184872,NCT04802837,NCT00426933,NCT00430937,NCT02202135,NCT00003805,NCT02607618,NCT00077675,NCT00003315,NCT02007603,NCT02374853,NCT05320068,NCT05266807,NCT02227446,NCT01984684,NCT00150852,NCT01499277,NCT01756924,NCT03196921,NCT03595553,NCT02600611,NCT01400867 |
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
RECQL,GALNT2,CASP6,EGFR,HPGD,XDH,FLT3,DRD1,TOP2A,APEX1,AHR,MET,CA12,CDK1,LMNA,TDP1,AURKB,TYR,PIM1,KDR,CA7,ADRA2A,HSD17B2,DPP4,SRC,CSNK2A2,FUT7,ALOX15,SNCA,ALOX5,AXL,POLH
|
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MET,KDR,EGFR
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
MET,SRC,KDR
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
ALOX5,RELA,AHR
|
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
EGFR,FLT3,KDR
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
INSR,RELA,DPP4
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
MET,KDR,SRC
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
ACHE,MET,AKR1B1
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
IGF1R,APEX1,TEK
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
MET,KDR,EGFR
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
DPP4
NCT04011618,NCT02337933 |
Metastatic malignant neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D50-2E09 |
HSPA1B,AXL,HSPA1A
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
DPP4
NCT04948814,NCT02504554 |
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
AHR,KDR,ALOX5
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
XDH,GLO1,ALOX5
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
FLT3,TEK,SRC
|
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
EGFR,CDK1,ALOX5
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
ALOX15,NOX4
NCT01912820 |
DiarrhoeaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05.1 |
NCT03462459,NCT00314951,NCT00269399
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT00050401,NCT04041791,NCT01798537
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT00008359,NCT00003938,NCT04733534
|
Bacterial pneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.0 |
NCT00107952,NCT00124020,NCT01570192
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
SMAD3,AXL,ACHE
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
AURKB,NPSR1,NOX4
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
ACHE,YES1,CYP1A1
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
POLH,HPGD,FUT7
|
Clostridium difficile enterocolitisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A04 |
NCT01598311,NCT01983683,NCT05256693,NCT02466698,NCT03617445,NCT03796650,NCT03105479,NCT01226992,NCT02148601,NCT03462459,NCT02179658,NCT01222702,NCT02686645,NCT00269399,NCT01987895,NCT02092935,NCT02743234,NCT01232595,NCT00314951,NCT04247542,NCT04138706,NCT00384527,NCT02801656,NCT02857582,NCT03827447,NCT01597505,NCT02865616,NCT02774382,NCT03030248
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
RECQL,HSD17B10,CASP6,EGFR,ACHE,TOP2A,APEX1,AHR,MET,CA12,CDK1,LMNA,TDP1,TP53,AKR1B1,AURKB,GLO1,KDR,ADRA2A,SRC,CISD1,CSNK2A2,CSNK2A1,NUAK1,TEK,AXL,POLH,NOX4
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
DPP4,NOX4,AKR1B1,FLT3,FUT7
NCT03636659,NCT01566552,NCT01310738,NCT00216346,NCT01032187,NCT04799236,NCT02025491,NCT01437020,NCT00832208,NCT00371995,NCT02656797,NCT01122771,NCT00523965,NCT00696969,NCT01067443,NCT01845727,NCT00497601,NCT00628719,NCT00876824,NCT02011958,NCT00370825 |
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
ALOX12,CASP6,ACHE,XDH,HPGD,DRD1,SLC22A6,AHR,MET,CA12,CDK1,AKR1B1,GLO1,KDR,HSD17B2,DPP4,SMAD3,FUT7,NPSR1,SNCA,ALOX5,CYP2C9,NUAK1,TEK,ABCG2,NOX4
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
HSPA1A,TEK,EGFR,ALOX5,APEX1,CA12,PIM1,RELA,MET,HSPA1B,TP53,IGF1R,AURKB,FLT3,TOP2A,YES1,AHR,RORC,CSNK2A1,SRC,CDK1,AXL,KDR,POLB,XDH
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
RECQL,POLB,ACHE,XDH,DRD1,MET,LMNA,AURKB,PIM1,CYP1B1,CA7,HSD17B2,DPP4,CISD1,CES1,FUT7,NPSR1,ALOX15,SNCA,ALOX5,CYP2C9,NUAK1,TEK,AXL,ABCG2
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
ALOX12,CASP6,XDH,HPGD,ELAVL3,APEX1,AHR,MET,CA12,CSNK2A3,TDP1,TP53,GLO1,YES1,CYP1A2,HSD17B2,RORC,CISD1,FUT7,ALOX15,ALOX5,CSNK2A1,POLH,NOX4
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
GALNT2,POLB,HSD17B10,CASP6,XDH,TOP2A,ELAVL3,MET,TDP1,TP53,AKR1B1,AURKB,GLO1,YES1,CA7,HSD17B2,DPP4,RORC,CISD1,FUT7,NPSR1,ALOX15,CYP19A1
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
ALOX5,RELA
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
ALOX5,IGF1R
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
EGFR,TOP2A
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
FLT3,TOP2A
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TOP2A,TP53
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
MET,KDR
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
AKR1B1,DRD1
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
TP53,SRC
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
RELA,ABCG2
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
AKR1B1,TOP2A
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
FLT3,ALOX5
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
AURKB
NCT04403568 |
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
DRD1,ACHE
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
SRC,EGFR
|
Psychotic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20-6A25 |
DRD1,INSR
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
ALOX5,TOP2A
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
TOP2A
NCT00455416 |
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
ADRA2A,ACHE
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
TP53,SRC
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
SRC,TP53
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
EGFR,MET
|
Inflammatory arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA2Z |
FLT3
NCT03506347 |
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
TP53
NCT02663596 |
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
SRC,ALOX5
|
Gastrointestinal stromal tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5B |
KDR,SRC
|
LeukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60-2B33 |
NCT00624143,NCT00002742
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
NCT01708278,NCT03989271
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
NCT02424734,NCT01551394
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04853199,NCT04851821
|
EndocarditisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB40-BA42 |
NCT00695903,NCT00871104
|
Bacterial cellulitis, erysipelas or lymphangitisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B70 |
NCT01252732,NCT01339091
|
Pyogenic abscess of the skinDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B75.3 |
NCT01339091,NCT01252732
|
Cystic fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA25 |
NCT01348204,NCT01594827
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT04075526,NCT05276895
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT03943459,NCT04907253
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT05422885,NCT04946383
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
CYP1A1
NCT03673956 |
Vaginal dischargeDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF3A |
NCT01293643,NCT01293643
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
CDK1,CYP1A1
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
PIM1,CYP2C9
|
Dengue fever, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D2Z |
ABCG2,AURKB
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
RORC,ABCG2
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
ABCG2,CYP1B1
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
AHR,NOX4
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
ALOX12,IGF1R,GPR35,TOP2A,ELAVL3,CSNK2A3,CDK1,LMNA,TP53,AKR1B1,AURKB,ADRA2A,SRC,SMAD3,ALOX5,CSNK2A1,NUAK1,L3MBTL1,NOX4
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
CA12,CDK1,AURKB,GPR35,L3MBTL1,TOP2A,SLC22A6,CYP19A1,NOX4,CA12,CDK1,SRC,AURKB,TOP2A,CYP19A1
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
GALNT2,HSD17B10,HPGD,ACHE,FLT3,DRD1,APEX1,AKR1B1,CYP1B1,HSD17B2,DPP4,CISD1,FUT7,ALOX15,CYP2C9
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
CA12,CDK1,DPP4,NOX4,CA7,AURKB,HPGD,GLO1,FUT7,TOP2A,ADRA2A,CYP19A1,MET,HSD17B2,SNCA
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
AURKB,ACHE,XDH,TYR,TOP2A,CYP19A1,ALOX5,CYP2C9,MET,AURKB,GPR35,FUT7,TOP2A,ALOX5
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
CA12,CDK1,NUAK1,SRC,AKR1B1,AURKB,IGF1R,GPR35,L3MBTL1,TOP2A,CYP19A1,NOX4
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
PIM1,AXL,TOP2A,FLT3,RELA,AURKB,SRC,TP53
NCT00451711,NCT00418951,NCT03187691 |
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
KDR,CYP19A1,CA12,AXL,SRC,EGFR,MET,IGF1R,TEK,CDK1,TOP2A
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
TOP2A,CA12,CYP2C9
NCT01283581,NCT00945152,NCT02426918,NCT01984684,NCT01811732,NCT04816968,NCT00423657,NCT00424190 |
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
CA12,CDK1,AURKB,ACHE,XDH,GPR35,NPSR1,TOP2A,CA7,ADRA2A,CYP2C9
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
ALOX5,MET,IGF1R,AXL,EGFR,TOP2A,KDR,CDK1,RORC,FLT3
|
AspergillosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F20 |
NCT04267497,NCT00334412,NCT00986713,NCT03327727,NCT00158730,NCT00047827,NCT00076869,NCT00003031,NCT00263315,NCT00001646
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
CDK1,AURKB,XDH,GPR35,NPSR1,TOP2A,ALOX15,CYP2C9,HSD17B2,CYP1A1
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
RELA
|
Unspecific substance harmful effectDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE6Z |
ACHE
|
Acquired hypomelanotic disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED63 |
TYR
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
XDH
|
Digestive organ benign neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E92 |
KDR
|
Gonococcal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A70-1A7Z |
TOP2A
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
MET
|
Lysosomal diseaseDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C56 |
INSR
|
Liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB90-DB9Z |
MET
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
DRD1
|
Extraocular muscle disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C82 |
IGF1R
|
Tic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A05 |
DRD1
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
ACHE
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
EGFR
|
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
ADRA2A
|
Ureteral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C92 |
AHR
|
EncephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E47 |
XDH
|
AbortionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA00 |
DRD1
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
EGFR
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
CSNK2A1
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
CYP19A1
|
Cocaine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C45 |
DRD1
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
DRD1
|
Mineral deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B5K |
XDH
|
ChemoprotectionDisease Category: NADisease ICD-11 Code: N.A. |
TOP2A
|
Common wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E80 |
TOP2A
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
MET
|
Acquired hypermelanosisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED60 |
TYR
|
Anogenital wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A95 |
TOP2A
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
SRC
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
TP53
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
TOP2A
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
TOP2A
|
MastocytosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A21 |
FLT3
|
Synthesis disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52-5C59 |
CES1
|
FilariasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F66 |
ALOX5
|
Unspecified viral infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D9Z |
FLT3
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
TP53
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
RELA
|
Synovial sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5A |
SRC
|
Hepatitis virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50-1E51 |
EGFR
|
Inborn purine/pyrimidine/nucleotide metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C55 |
XDH
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
RELA
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
ADRA2A
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
AKR1B1
|
Type-1/2 diabeteDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10-5A11 |
INSR
|
Intracerebral haemorrhageDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B00 |
EGFR
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
TOP2A
|
Oesophageal/gastroduodenal disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD90 |
ACHE
|
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
TOP2A
|
Autoimmune diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40-4A45 |
RORC
|
LeiomyosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B58 |
SRC
|
Parasitic worm infestationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F90 |
ACHE
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
CYP19A1
|
SyphilisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A61-1A6Z |
TOP2A
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
EGFR
|
Autonomic nervous system disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D87 |
SNCA
|
Colon cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
EGFR
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
FLT3
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA12
|
Ocular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D00-2D07 |
APEX1
|
Metastatic biliary tract neoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C14-2C17 |
EGFR
|
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
ACHE
|
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
CES1
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
DPP4
|
Epidermal dysplasiasDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK90 |
SRC
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
EGFR
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
TOP2A
|
Skin postprocedural disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EL8Y |
EGFR
|
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
EGFR
|
LiposarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B59 |
TP53
|
Carcinoid syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B10 |
ALOX5
|
Bone/articular cartilage neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7B |
FLT3
|
Transplanted organ/tissueDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QB63 |
FLT3
|
Spinal cord/cranial nerve neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A02 |
EGFR
|
Opioid use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C43 |
ADRA2A
|
ThyrotoxicosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A02 |
IGF1R
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
CYP19A1
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
XDH
|
Human immunodeficiency virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C60-1C62 |
FLT3
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
RELA
|
Peroxisomal diseaseDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C57 |
CES1
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
TP53
|
Multiple structural anomalies syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2F |
IGF1R
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
RELA
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
TP53
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
SRC
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
RELA
|
PediculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G00 |
ACHE
|
Ovarian dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80 |
TP53
|
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
TOP2A
|
Phakomatoses/hamartoneoplastic syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2D |
FLT3
|
HistoplasmosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F2A |
NCT00002159
|
BlastomycosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F22 |
NCT00002159
|
Infection of amniotic sac or membranesDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA88.1 |
NCT00879190
|
Other specified conjunctivitisDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A60.Y |
NCT02432807
|
Congenital aplastic anaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A70.0 |
NCT01720147
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
NCT02037295
|
NosocomialDisease Category: X.Extension CodesDisease ICD-11 Code: XB25 |
NCT01515020
|
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT03187691
|
Ventilation associated with injury or harm in therapeutic useDisease Category: 23.External causes of morbidity or mortalityDisease ICD-11 Code: PK81.0 |
NCT00543608
|
ConstipationDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05.0 |
NCT02301221
|
Endothelial corneal dystrophyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A70.0 |
NCT04018417
|
Pneumonia due to StaphylococcusDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.06 |
NCT01925066
|
Chronic mucocutaneous candidosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F23.14 |
NCT02629419
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT04025567
|
Lichen planusDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA91 |
NCT01375101
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT01438320
|
Other specified increased intracranial pressureDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D60.Y |
NCT00000776
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT05062486
|
Dysplastic naevusDisease Category: X.Extension CodesDisease ICD-11 Code: XH9035 |
NCT00346502
|
PeritonitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DC50 |
NCT03685747
|
Gastro-oesophageal reflux diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA22 |
NCT02226484
|
Sepsis of fetus or newbornDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA60 |
NCT02790996
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00002742
|
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT03817125
|
Aspergillus-induced allergic or hypersensitivity conditionsDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA82.4 |
NCT01857479
|
Dystonic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A02 |
NCT01433757
|
Intermediate hyperglycaemia, unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A40.Z |
NCT02730962
|
Malignant neoplasms of other or unspecified parts of mouthDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B66 |
NCT05456022
|
Cleft palateDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA42 |
NCT00760006
|
Graft-versus-host diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B24 |
NCT02641236
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
NOX4
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
CA7
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
DPP4
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
NOX4
|
Dilated cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.0 |
ABCG2
|
Lyme borreliosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C1G |
MET
|